Lai-Ming Ching Explained
Lai-Ming Ching |
Fields: | Cellular biology |
Alma Mater: | University of Auckland |
Thesis1 Title: | Analysis of clones of cytotoxic lymphocytes |
Thesis1 Url: | http://hdl.handle.net/2292/2087 |
Thesis1 Year: | 1987 |
Doctoral Advisor: | J. Marbrook |
Lai-Ming Ching is a New Zealand cellular biology academic, and as of 2019 is a full professor at the University of Auckland.[1]
Academic career
After gaining a PhD in 1978 and producing a doctoral thesis titled 'Analysis of clones of cytotoxic lymphocytes' at the University of Auckland, Ching joined the staff, rising to full professor.[2] [1]
Much of Ching's research relates to the identification of potential anti-cancer drugs.[3]
Selected works
- Ching, Lai-Ming, and Bruce C. Baguley. "Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347 512)." European Journal of Cancer and Clinical Oncology 23, no. 7 (1987): 1047–1050.
- Thomsen, Lindy L., Lai-Ming Ching, Li Zhuang, John B. Gavin, and Bruce C. Baguley. "Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice." Cancer research 51, no. 1 (1991): 77–81.
- Roberts, Zachary J., Nadege Goutagny, Pin-Yu Perera, Hiroki Kato, Himanshu Kumar, Taro Kawai, Shizuo Akira et al. "The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis." Journal of Experimental Medicine 204, no. 7 (2007): 1559–1569.
- Thomsen, Lindy L., Lai-Ming Ching, and Bruce C. Baguley. "Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid." Cancer research 50, no. 21 (1990): 6966–6970.
Notes and References
- Web site: Professor Lai-Ming Ching – The University of Auckland . unidirectory.auckland.ac.nz .
- Ching . Lai-Ming . 1978 . Doctoral thesis . Analysis of clones of cytotoxic lymphocytes . ResearchSpace@Auckland, University of Auckland . 2292/2087 .
- News: New cancer drug 'could be a blockbuster' . Martin . Johnston . 5 April 2016 . . 8 April 2019.